Eirik Næss-Ulseth
Gründer bei Spermatech AS
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bjørn Steen Skålhegg | M | 65 |
Spermatech AS
 Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | 22 Jahre |
| Tore Jahnsen | M | 70 |
Rheumatech AS
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | - |
| Gunnar Hvammen | M | 61 |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | - |
| Håvard Hildeng Hauge | M | 55 |
Biomolex AS
 Biomolex AS Medical SpecialtiesHealth Technology Biomolex AS develops and delivers imaging systems for digital autoradiography. It offers Biomolex 700, a digital imager for protein micro-array analysis, including kinase analyses, protein interaction assays, single istotope deoxyribonucleic acid array analyses, micro analyses; and tissue imaging applications, such as foreign genetic material delivery, tissue specific distributions, uptake of antibodies, and uptake of labeled bio-molecules. The company was founded in May 2001 and is headquartered in Oslo, Norway. | 23 Jahre |
| Ken Roger Rosendal | M | 52 |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | - |
| Tuva Holt Hereng | M | - |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | 12 Jahre |
| Sigurd Ørstavik | M | 55 |
Spermatech AS
Spermatech AS Pharmaceuticals: MajorHealth Technology Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Norwegen | 7 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Eirik Næss-Ulseth
- Persönliches Netzwerk
